Johnson & Johnson (NYSE:JNJ) Shares Sold by HHM Wealth Advisors LLC

Posted by Defense World Staff on Mar 30th, 2023

HHM Wealth Advisors LLC lessened its position in Johnson & Johnson (NYSE:JNJ – Get Rating) by 8.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,269 shares of the company’s stock after selling 309 shares during the period. HHM Wealth Advisors LLC’s holdings in Johnson & Johnson were worth $577,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Glassy Mountain Advisors Inc. purchased a new stake in Johnson & Johnson in the fourth quarter valued at approximately $35,000. Retirement Financial Solutions LLC purchased a new stake in Johnson & Johnson in the fourth quarter valued at approximately $40,000. TD Capital Management LLC purchased a new stake in Johnson & Johnson in the third quarter valued at approximately $48,000. Iron Horse Wealth Management LLC grew its holdings in Johnson & Johnson by 112.8% in the fourth quarter. Iron Horse Wealth Management LLC now owns 300 shares of the company’s stock valued at $53,000 after purchasing an additional 159 shares during the period. Finally, Piershale Financial Group Inc. purchased a new stake in Johnson & Johnson in the fourth quarter valued at approximately $61,000. Institutional investors and hedge funds own 67.94% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. StockNews.com started coverage on shares of Johnson & Johnson in a report on Thursday, March 16th. They issued a “strong-buy” rating for the company. Morgan Stanley boosted their price objective on shares of Johnson & Johnson from $176.00 to $180.00 and gave the stock an “equal weight” rating in a research note on Wednesday, January 25th. Cantor Fitzgerald restated an “overweight” rating and issued a $215.00 target price on shares of Johnson & Johnson in a research note on Wednesday, February 1st. SVB Leerink decreased their target price on shares of Johnson & Johnson from $194.00 to $186.00 and set an “outperform” rating for the company in a research note on Friday, January 20th. Finally, Piper Sandler decreased their target price on shares of Johnson & Johnson from $55.00 to $52.00 in a research note on Monday, February 6th. Eight research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $173.67.

Johnson & Johnson Stock Up 1.0 %

Johnson & Johnson stock opened at $153.31 on Thursday. The company has a 50-day simple moving average of $158.62 and a 200-day simple moving average of $167.29. The firm has a market capitalization of $399.26 billion, a P/E ratio of 22.75, a P/E/G ratio of 2.63 and a beta of 0.54. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.77 and a current ratio of 0.99. Johnson & Johnson has a one year low of $150.11 and a one year high of $186.69.

Johnson & Johnson (NYSE:JNJ – Get Rating) last released its quarterly earnings results on Tuesday, January 24th. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $2.22 by $0.13. The business had revenue of $23.71 billion during the quarter, compared to analyst estimates of $23.90 billion. Johnson & Johnson had a net margin of 18.90% and a return on equity of 35.76%. The company’s quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.13 earnings per share. As a group, equities analysts expect that Johnson & Johnson will post 10.5 earnings per share for the current year.

Johnson & Johnson Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 7th. Investors of record on Tuesday, February 21st were given a $1.13 dividend. The ex-dividend date was Friday, February 17th. This represents a $4.52 dividend on an annualized basis and a yield of 2.95%. Johnson & Johnson’s dividend payout ratio is presently 67.06%.

Insider Activity at Johnson & Johnson

In related news, insider James D. Swanson sold 1,062 shares of the stock in a transaction dated Monday, March 6th. The shares were sold at an average price of $154.66, for a total value of $164,248.92. Following the completion of the transaction, the insider now owns 9,215 shares in the company, valued at approximately $1,425,191.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.35% of the stock is currently owned by insiders.

Johnson & Johnson Profile

(Get Rating)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets.